Literature DB >> 18544067

Basal cell carcinomas arising within multiple trichoepitheliomas.

Laura B Pincus1, Timothy H McCalmont, Isaac M Neuhaus, Richard Kasper, Dennis H Oh.   

Abstract

Although trichoepitheliomas (TEs) are commonly regarded as benign tumors of follicular origin, the natural history of multiple familial trichoepitheliomas (MFT) and their risk for malignancy has been unclear. We describe a 57-year-old male with numerous skin-colored firm papules and plaques present on the central face since 6 years of age. Recently, some lesions had enlarged and ulcerated. Other family members were similarly affected. Biopsies from multiple lesions showed TEs both alone and associated with basal cell carcinoma (BCC) in the same section, suggesting the secondary development of BCCs within TEs. Many prior reports of BCCs arising within TEs in patients with presumed MFT were likely misdiagnosed cases of nevoid BCC. This report is a compelling example of MFT in which BCCs evolved secondarily. Awareness of the potential for the evolution of carcinoma in patients with MFT is important in the management of these patients. Copyright Blackwell Munksgaard 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544067     DOI: 10.1111/j.1600-0560.2008.01002.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Trichoepithelioma and Basal Cell Carcinoma with Squamous Differentiation: Is it Causal or Coincidental?

Authors:  Palak Agarwal; Charu Agarwal; Minakshi Bhardwaj; Arvind Ahuja; Seema Rani
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

Review 2.  Brooke-Spiegler Syndrome and Phenotypic Variants: An Update.

Authors:  Dmitry V Kazakov
Journal:  Head Neck Pathol       Date:  2016-03-14

Review 3.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.